🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 28/11/1977 | 0,0113 USD |
| 29/08/1977 | 0,0099 USD |
| 31/05/1977 | 0,0099 USD |
| 01/03/1977 | 0,0099 USD |
| 30/11/1976 | 0,0099 USD |
| 30/08/1976 | 0,0093 USD |
| 01/06/1976 | 0,0093 USD |
| 02/03/1976 | 0,0093 USD |
| 01/12/1975 | 0,0093 USD |
| 29/08/1975 | 0,0093 USD |
| 02/06/1975 | 0,0093 USD |
| 03/03/1975 | 0,0093 USD |
| 30/08/1974 | 0,0093 USD |
| 03/06/1974 | 0,0093 USD |
| 04/03/1974 | 0,0093 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 18/05/2004 | 44,61 | 44,85 | 44,50 | 44,70 | +0,45% | 0,77% | 3.989.107 |
| 17/05/2004 | 43,89 | 44,74 | 43,89 | 44,50 | +0,41% | 1,93% | 4.880.641 |
| 14/05/2004 | 43,89 | 44,79 | 43,89 | 44,32 | +0,76% | 2,04% | 4.665.696 |
| 13/05/2004 | 44,27 | 44,64 | 43,95 | 43,99 | -1,60% | 1,55% | 5.366.389 |
| 12/05/2004 | 43,94 | 44,85 | 43,76 | 44,70 | +0,97% | 2,48% | 5.186.447 |
| 11/05/2004 | 44,56 | 44,60 | 43,88 | 44,27 | -0,66% | 1,61% | 6.697.244 |
| 10/05/2004 | 44,90 | 45,36 | 44,05 | 44,57 | -2,10% | 2,93% | 9.195.571 |
| 07/05/2004 | 45,92 | 46,19 | 45,52 | 45,52 | -0,83% | 1,48% | 6.956.310 |
| 06/05/2004 | 45,61 | 46,16 | 45,50 | 45,91 | +0,63% | 1,46% | 5.994.036 |
| 05/05/2004 | 45,61 | 45,93 | 45,47 | 45,62 | -0,08% | 1,00% | 4.903.173 |
| 04/05/2004 | 45,66 | 45,76 | 45,33 | 45,66 | +0,31% | 0,94% | 5.666.955 |
| 03/05/2004 | 44,86 | 45,57 | 44,86 | 45,52 | +1,49% | 1,60% | 5.782.445 |
| 30/04/2004 | 44,85 | 45,32 | 44,81 | 44,85 | +0,04% | 1,15% | 4.851.716 |
| 29/04/2004 | 45,18 | 45,23 | 44,71 | 44,83 | -0,97% | 1,14% | 5.811.055 |
| 28/04/2004 | 45,09 | 45,32 | 44,85 | 45,27 | +0,40% | 1,06% | 6.195.881 |
| 27/04/2004 | 44,75 | 45,42 | 44,71 | 45,09 | +1,31% | 1,58% | 6.138.870 |
| 26/04/2004 | 44,66 | 44,83 | 44,48 | 44,50 | -0,26% | 0,77% | 3.817.026 |
| 23/04/2004 | 44,99 | 44,99 | 44,27 | 44,62 | +0,04% | 1,61% | 4.012.687 |
| 22/04/2004 | 44,13 | 44,99 | 43,69 | 44,60 | +0,52% | 2,94% | 7.468.886 |
| 21/04/2004 | 43,99 | 45,08 | 43,94 | 44,37 | +0,63% | 2,58% | 6.093.806 |
| 20/04/2004 | 44,79 | 44,79 | 44,08 | 44,09 | -1,56% | 1,58% | 4.708.035 |
| 19/04/2004 | 44,75 | 44,90 | 44,38 | 44,79 | -0,30% | 1,17% | 5.784.122 |
| 16/04/2004 | 45,09 | 45,21 | 44,58 | 44,92 | +0,21% | 1,40% | 8.015.418 |
| 15/04/2004 | 43,56 | 44,99 | 43,56 | 44,83 | +3,39% | 3,29% | 13.231.838 |
| 14/04/2004 | 42,37 | 43,42 | 42,27 | 43,36 | +1,93% | 2,70% | 9.200.916 |
| 13/04/2004 | 42,87 | 43,03 | 42,35 | 42,54 | -0,69% | 1,60% | 6.373.517 |
| 12/04/2004 | 42,59 | 42,94 | 42,37 | 42,83 | +0,58% | 1,34% | 5.454.106 |
| 08/04/2004 | 43,02 | 43,13 | 42,25 | 42,59 | -0,47% | 2,04% | 6.343.125 |
| 07/04/2004 | 43,08 | 43,18 | 42,71 | 42,79 | -0,69% | 1,09% | 5.138.239 |
| 06/04/2004 | 42,94 | 43,08 | 42,86 | 43,08 | -0,31% | 0,51% | 5.487.014 |